Response.
NotesAffiliations of authors: Department of Internal Medicine and Department of Pharmacology, Michigan Medical School, Ann Arbor, MI (JMR); Edith Sanford Breast Cancer Research, Sanford Health and Research, Sioux Falls, SD (BL-J); Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA (MR). jimmyrae@umich.edu.
James M
JM
Rae
NotesAffiliations of authors: Department of Internal Medicine and Department of Pharmacology, Michigan Medical School, Ann Arbor, MI (JMR); Edith Sanford Breast Cancer Research, Sanford Health and Research, Sioux Falls, SD (BL-J); Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA (MR).
Brian
B
Leyland-Jones
NotesAffiliations of authors: Department of Internal Medicine and Department of Pharmacology, Michigan Medical School, Ann Arbor, MI (JMR); Edith Sanford Breast Cancer Research, Sanford Health and Research, Sioux Falls, SD (BL-J); Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA (MR).
Meredith
M
Regan
D001943:Breast Neoplasms / Q000201:enzymology* / Q000235:genetics*; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics* / Q000378:metabolism*; D004273:DNA, Neoplasm; D005260:Female; D006801:Humans
D004273:DNA, Neoplasm; D019389:Cytochrome P-450 CYP2D6